When was MicroBiopharm Japan founded?

MicroBiopharm Japan was founded in 2011 and raised its 1st funding round within a year of its incorporation.

Where is MicroBiopharm Japan located?

MicroBiopharm Japan is headquartered in Tokyo, Japan.

Who is the current CEO of MicroBiopharm Japan?

Suzuki Masan of MicroBiopharm Japan.

How many employees does MicroBiopharm Japan have?

As of Aug 31, 2026, the latest employee count at MicroBiopharm Japan is 6.

Is MicroBiopharm Japan a funded company?

MicroBiopharm Japan is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jan 01, 2011.

When was the latest funding round of MicroBiopharm Japan?

MicroBiopharm Japan's latest funding was a $***** Seed round on Jan 01, 2011, with participation from 1 investor.

Where does MicroBiopharm Japan rank among its competitors?

MicroBiopharm Japan ranks 4th amongst 36 active competitors, of which 5 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Culture Biosciences, which secured an undisclosed amount in Dec, 2025.

Who are the top competitors of MicroBiopharm Japan?

MicroBiopharm Japan's top competitors include Culture Biosciences, PBS Biotech and Bionet Engineering. Among them, Culture Biosciences secured the most recent funding round in December, 2025.

MicroBiopharm Japan - 2026 Company Profile, Team, Funding & Competitors

Company Details

MicroBiopharm Japan (MBJ) provides contract research services to the biopharma companies. It provides fermentation services and services for strain and process Improvement. The company is using its microorganism, P450 (Physical property improvement by hydroxylation) and vitamin D derivatives libraries to provide drug discovery services. Its product portfolio includes Anthracycline analogs, Macrolide analog, Calcitriol, Paricalcitol, Pipecolic acid analogs, Vitamin D Analogue and Cyclodextrins.

Key Metrics

Founded Year

2011

Location

Tokyo, Japan

Stage

Acquired

Total Funding

$124K in 1 round

Latest Funding Round

Seed, Jan 01, 2011, $*****

Investors

Toray Industries & 1 more

Ranked

4^th among 36 active competitors

Employee Count

6 as on Aug 31, 2026

Similar Companies

Culture Biosciences & 39 more

Exit Details

Acquired by Gujarat Themis Biosyn (May 25, 2026)

View MicroBiopharm Japan's full profile

MicroBiopharm Japan is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MicroBiopharm Japan Co., Ltd. CIN: 1180001096897 , Japan, Active	Jul 01, 2011	-	-	-

MicroBiopharm Japan got acquired by Gujarat Themis Biosyn on May 25, 2026.

Click here to take a look at MicroBiopharm Japan's acquisition in detail

MicroBiopharm Japan has raised a total funding of $124K over 1 round. Its latest funding round was a Seed round on Jan 01, 2011 for $*****. 1 investor participated in its latest round. MicroBiopharm Japan has 2 institutional investors.

Here is the list of recent funding rounds of MicroBiopharm Japan:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 01, 2011	3443844	Seed	8820999	3679961	4860132	8116775

Access funding benchmarks and valuations. Sign up today!

View details of MicroBiopharm Japan's funding rounds and investors

MicroBiopharm Japan's employee count trend

MicroBiopharm Japan has 6 employees as of Aug 26. Here is MicroBiopharm Japan's employee count trend over the years:

Employee count trend for MicroBiopharm Japan

Uncover MicroBiopharm Japan's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MicroBiopharm Japan include Culture Biosciences, PBS Biotech and Bionet Engineering. Here is the list of Top 10 competitors of MicroBiopharm Japan, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Culture Biosciences 2016, San Francisco (United States), Series C	Provider of biomanufacturing hardware and software tools for research purposes	$107M	Northpond Ventures, Cultivian Sandbox & 22 others	69/100
2nd	PBS Biotech 2006, Camarillo (United States), Series B	Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies	$70.2M	Avego, CYwP Funds & 2 others	56/100
3rd	Bionet Engineering 1999, Santiago Papasquiaro (Mexico), Unfunded	Provider of products and services for bioprocess engineering	-	-	48/100
4th	MicroBiopharm Japan 2011, Tokyo (Japan), Acquired	Provides discovery and contract research services to the biopharma companies	$124K	Toray Industries, T Capital Partners	46/100
5th	Membio 2018, Kitchener (Canada), Seed	Developer of single-use bioreactors for cell and gene therapies	$280K	IndieBio, Accelerator Centre & 7 others	40/100
6th	m2p-labs 2005, Baesweiler (Germany), Acquired	Bioreactors for screening and bioprocess development	-	FIDURA, S-UBG & 4 others	38/100
7th	Amino 2015, Toronto (Canada), Seed	Provider of lab equipment for bacterial transformations and culture growth	$250K	IndieBio, SOSV & 2 others	35/100
8th	Innovel Intelligent Technology 2018, Suzhou (China), Series A	Provider of bioreactors for cell culture	$15.3M	-	34/100
9th	CARR Biosystems 1993, Clearwater (United States), Funding Raised	Developer of bioprocessing solutions for biotech industries	-	BW Forsyth Partners	30/100
10th	Distek 1976, North Brunswick (United States), Unfunded	Pharmaceutical and bioprocessing lab instruments and qualification services provider	-	-	29/100